Abstract:OBJECTIVE:To evaluate safety, efficacy, and long-term outcomes of photoselective vaporization of prostate using 120-W HPS GreenLight KTP laser and compare the results with those obtained with 2-micrometer continuous-wave (2 um CW) laser for treatment of patients with benign prostatic hyperplasia (BPH).MATERIALS AND METHODS:One group of 216 patients diagnosed with BPH underwent 120-W KTP laser vaporization of the prostate, while another group of 198 BPH patients underwent 2 um CW laser vaporization. The relevant pre-, peri-, and post-operative parameters were compared between the two therapy groups. Functional results in terms of improvement of International Prostate Symptom Score (IPSS), maximum flow rate (Qmax), and post-void residual (PVR) urine were assessed at 3, 6, 12, and 24 months.RESULTS:BPH was successfully treated with 120-W HPS KTP laser and 2 um CW laser in all patients. There were no significant difference between two patient groups in the baseline characteristics (such as PSA, IPSS, QoL, and Qmax). No major complications occurred intraoperatively (capsule perforation and TUR syndrome) or postoperatively (electric unbalance), and no blood transfusions were required in both groups. Average catheterization time was 1.9±1.3 days for the 120-W PVP and 2.2±1.9 days for the 2 um CW laser treatment. In addition, the hospitalization times were 3.8±1.2days (120-W PVP) and 4.8±1.5 days (2 um CW laser), respectively. The incidence of dysuria and urge incontinence was higher in the 2 um CW laser group (35/198, 24/198) than in the 120 W PVP group (15/216, 10/216). Dramatic improvement was observed in Qmax, IPSS, Qol, and PVR as compared with the respective pre-operative values. The degree of improvement during the follow-up period was comparable in both groups. No significant differences were observed in terms of re-operation rates, bladder neck stricture, and urethral stricture.CONCLUSIONS:Both 120-W HPS laser and 2 um CW laser vaporization present effective treatment options in patients with BPH, but 120-W PVP provides safer therapy with less post-operative complications within the 2-year follow-up period.

Experience of treating high risk prostate hyperplasia patients with a HPS120 laser

Evaluation of 80-W and 120-W GreenLight Laser Vaporization for Benign Prostatic Hyperplasia in High-Risk Patients

Efficacy of GreenLight 180 W vs.120 W laser systems in the treatment of high-risk benign prostate hyperplasia in elderly patients with prostate over 80 g

[Effect and safety of GreenLight HPS 120-W laser vaporization of the prostate for different benign prostatic hyperplasia populations]

Clinical efficiency of 120W diode laser vaporization for benign prostate hyperplasia：report of 57 cases

Photoselective potassium-titanyl-phosphate laser vaporization prostatectomy for the treatment of high-risk patients with benign prostatic hyperplasia

The Application of 120-W High-Performance System GreenLight Laser Vaporization of the Prostate in High-Risk Patients

Photo-Selective Vaporization Of The Prostate With Green-Light Hps 120-W Laser For Benign Prostatic Hyperplasia: 36 Months' Follow-Up

Application of 120 W 2 Μm Laser Prostate Vaporesection in the Treatment of Benign Prostatic Hyperplasia

160-Watt Domestic High Power Greenlight Photoselective Vaporization of Large-Gland Benign Prostatic Hyperplasia

GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a prospective randomized trial.

[Safety and Effectiveness of GreenLight 120-W Laser Photoselective Vaporization of the Prostate for Benign Prostatic Hyperplasia: A Meta-Analysis].

Greenlight photoselective vaporization prostatectomy for the treatment of benign prostatic hyperplasia

Comparison of Vaporization Using 120-W GreenLight Laser Versus 2-Micrometer Continuous Laser for Treating Benign Prostatic Hyperplasia: A 24-Month Follow-Up Study of a Single Center

5-year long-term efficacy of 120-W GreenLight photoselective vaporization of the prostate for benign prostate hyperplasia

[Transurethral 180 W front-firing GreenLight laser vaporization of the prostate for the treatment of benign prostatic hyperplasia]

Photoselective Vaporization of the Prostate with GreenLight 120-W Laser Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: a Systematic Review with Meta-Analysis of Randomized Controlled Trials

Clinical research on the treatment of benign prostatic hyperplasia patients complicated with bladder cal‐culi with 160 W green‐light laser photoselective vaporization of prostate and transurethral holmium laser cystolithotripsy

Short-term Clinical Evaluation of Photoselective Vaporization of the Prostate for the Patients with Benign Hyperplasia of Prostate in Anti-Coagulanting Status

Clinical observation of bipolar plasmakinetic combined with green laser in treatment of larger volume benign prostate hyperplasia

A Comparative Study of Clinical Effects of 120W Greenlight Photoselective Vaporization of Prostate Vs Transurethral Resection of Prostate for Treatment of Benign Prostatic Hyperplasia